IMMUNIC, INC. Quarterly Depreciation in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immunic, Inc. quarterly Depreciation history and growth rate from Q2 2018 to Q3 2024.
  • Immunic, Inc. Depreciation for the quarter ending September 30, 2024 was $42K, a 23.5% increase year-over-year.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $42K +$8K +23.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $31K +$9K +40.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $26K -$6K -18.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q3 2023 $34K +$17K +100% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $22K +$2K +10% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $32K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q3 2022 $17K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $20K +$5K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $32K +$18K +129% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $17K +$1K +6.25% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $15K +$9K +150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $14K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $16K +$7K +77.8% Jul 1, 2020 Sep 30, 2020 10-Q 2022-11-03
Q2 2020 $6K -$18K -75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $14K +$9K +180% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $9K +$6K +200% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $24K +$20K +500% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-03
Q1 2019 $5K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 $3K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $4K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.